Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Natural Killer Group 2D Receptor (NKG2D)
- Target
- NKG2D
- Molecular classification
- C-type lectin-like receptor, Activating receptor
01
Overview
NKG2D is a transmembrane activating receptor that plays a central role in immune surveillance by recognizing stress-induced ligands on target cells. It is expressed on NK cells, CD8+ T cells, and other immune cells, and triggers cytotoxic responses upon ligand binding. It modulates activation thresholds for other receptors and is crucial for tumor immunosurveillance and antiviral immunity. Potential applications include cancer immunotherapy and modulation strategies for autoimmune diseases.
- Other names
- KLRK1
02
Mechanism of action
Directly triggers cytotoxicity upon ligand engagement on NK cells; provides co-stimulatory signals on CD8+ T cells
03
Biological functions
Immune surveillanceCytotoxicityCo-stimulationRegulation of immune responses
04
Disease associations
Tumor immunosurveillanceAntiviral immunityAutoimmunityTransplant rejection/acceptanceBacterial infections
05
Safety considerations
Potential for excessive tissue damage during inflammationAutoimmunityOn-target, off-tumor effects in cancer immunotherapy
06
Biomarkers
NKG2D ligand expression levels on tumor cellsKLRK1 polymorphisms
Beyond the preview
Go deeper on Natural Killer Group 2D Receptor (NKG2D).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Natural Killer Group 2D Receptor (NKG2D).